217 related articles for article (PubMed ID: 7690776)
1. The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma).
Kuwana M; Kaburaki J; Okano Y; Inoko H; Tsuji K
J Clin Invest; 1993 Sep; 92(3):1296-301. PubMed ID: 7690776
[TBL] [Abstract][Full Text] [Related]
2. Different distribution of HLA class II alleles in anti-topoisomerase I autoantibody responders between silicosis and systemic sclerosis patients, with a common distinct amino acid sequence in the HLA-DQB1 domain.
Ueki A; Isozaki Y; Tomokuni A; Ueki H; Kusaka M; Tanaka S; Otsuki T; Sakaguchi H; Hyodoh F
Immunobiology; 2001 Dec; 204(4):458-65. PubMed ID: 11776400
[TBL] [Abstract][Full Text] [Related]
3. Association of HLA class II genes with systemic sclerosis in Koreans.
Kang SH; Park MH; Song EY; Kang SJ; Lee EB; Song YW; Takeuchi F
J Rheumatol; 2001 Jul; 28(7):1577-83. PubMed ID: 11469465
[TBL] [Abstract][Full Text] [Related]
4. MHC class II associations with autoantibody and T cell immune responses to the scleroderma autoantigen topoisomerase I.
Rands AL; Whyte J; Cox B; Hall ND; McHugh NJ
J Autoimmun; 2000 Dec; 15(4):451-8. PubMed ID: 11090244
[TBL] [Abstract][Full Text] [Related]
5. Autoreactive T cells to topoisomerase I in monozygotic twins discordant for systemic sclerosis.
Kuwana M; Feghali CA; Medsger TA; Wright TM
Arthritis Rheum; 2001 Jul; 44(7):1654-9. PubMed ID: 11465716
[TBL] [Abstract][Full Text] [Related]
6. Association of HLA-DR with progressive systemic sclerosis in Japanese.
Takeuchi F; Nakano K; Yamada H; Hong GH; Nabeta H; Yoshida A; Matsuta K; Bannai M; Tokunaga K; Ito K
J Rheumatol; 1994 May; 21(5):857-63. PubMed ID: 8064726
[TBL] [Abstract][Full Text] [Related]
7. Highly restricted TCR-alpha beta usage by autoreactive human T cell clones specific for DNA topoisomerase I: recognition of an immunodominant epitope.
Kuwana M; Medsger TA; Wright TM
J Immunol; 1997 Jan; 158(1):485-91. PubMed ID: 8977226
[TBL] [Abstract][Full Text] [Related]
8. An immunodominant epitope on DNA topoisomerase I is conformational in nature: heterogeneity in its recognition by systemic sclerosis sera.
Kuwana M; Kaburaki J; Medsger TA; Wright TM
Arthritis Rheum; 1999 Jun; 42(6):1179-88. PubMed ID: 10366110
[TBL] [Abstract][Full Text] [Related]
9. Studies of HLA-DR and DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin).
Falkner D; Wilson J; Fertig N; Clawson K; Medsger TA; Morel PA
J Rheumatol; 2000 May; 27(5):1196-202. PubMed ID: 10813287
[TBL] [Abstract][Full Text] [Related]
10. Antibody specificities of Thai and Australian scleroderma sera with topoisomerase I recombinant fusion proteins.
Cram DS; Fisicaro N; McNeilage LJ; Coppel RL; Harrison LC
J Immunol; 1993 Dec; 151(12):6872-81. PubMed ID: 7505017
[TBL] [Abstract][Full Text] [Related]
11. Different distribution of HLA class II and tumor necrosis factor alleles (TNF-308.2, TNFa2 microsatellite) in anti-topoisomerase I responders among scleroderma patients with and without exposure to quartz/metal dust.
Frank KH; Füssel M; Conrad K; Rihs HP; Koch R; Gebhardt B; Mehlhorn J
Arthritis Rheum; 1998 Jul; 41(7):1306-11. PubMed ID: 9663489
[TBL] [Abstract][Full Text] [Related]
12. Severe systemic sclerosis with anti-topoisomerase I antibodies is associated with an HLA-DRw11 allele.
Morel PA; Chang HJ; Wilson JW; Conte C; Saidman SL; Bray JD; Tweardy DJ; Medsger TA
Hum Immunol; 1994 Jun; 40(2):101-10. PubMed ID: 7928439
[TBL] [Abstract][Full Text] [Related]
13. HLA-associated production of anti-DFS70/LEDGF autoantibodies and systemic autoimmune disease.
Muro Y; Ogawa Y; Sugiura K; Tomita Y
J Autoimmun; 2006 Jun; 26(4):252-7. PubMed ID: 16713178
[TBL] [Abstract][Full Text] [Related]
14. Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus.
Simon D; Czömpöly T; Berki T; Minier T; Peti A; Tóth E; Czirják L; Németh P
Int Immunol; 2009 Apr; 21(4):415-22. PubMed ID: 19211583
[TBL] [Abstract][Full Text] [Related]
15. Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody.
Kuwana M; Kaburaki J; Arnett FC; Howard RF; Medsger TA; Wright TM
Arthritis Rheum; 1999 Mar; 42(3):465-74. PubMed ID: 10088769
[TBL] [Abstract][Full Text] [Related]
16. T and B cell collaboration is essential for the autoantibody response to DNA topoisomerase I in systemic sclerosis.
Kuwana M; Medsger TA; Wright TM
J Immunol; 1995 Sep; 155(5):2703-14. PubMed ID: 7650398
[TBL] [Abstract][Full Text] [Related]
17. B-Cell epitope mapping of DNA topoisomerase I defines epitopes strongly associated with pulmonary fibrosis in systemic sclerosis.
Rizou C; Ioannidis JP; Panou-Pomonis E; Sakarellos-Daitsiotis M; Sakarellos C; Moutsopoulos HM; Vlachoyiannopoulos PG
Am J Respir Cell Mol Biol; 2000 Mar; 22(3):344-51. PubMed ID: 10696071
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies detectable in the sera of silicosis patients. The relationship between the anti-topoisomerase I antibody response and HLA-DQB1*0402 allele in Japanese silicosis patients.
Ueki A; Isozaki Y; Tomokuni A; Tanaka S; Otsuki T; Kishimoto T; Kusaka M; Aikoh T; Sakaguchi H; Hydoh F
Sci Total Environ; 2001 Apr; 270(1-3):141-8. PubMed ID: 11327387
[TBL] [Abstract][Full Text] [Related]
19. T cell lines from systemic sclerosis patients and healthy controls recognize multiple epitopes on DNA topoisomerase I.
Hu PQ; Oppenheim JJ; Medsger TA; Wright TM
J Autoimmun; 2006 Jun; 26(4):258-67. PubMed ID: 16735104
[TBL] [Abstract][Full Text] [Related]
20. HLA-DRB1 and DQB1 genes in Japanese patients with systemic sclerosis.
Akimoto S; Abe M; Ishikawa O
J Rheumatol; 2000 Dec; 27(12):2940-2. PubMed ID: 11128693
[No Abstract] [Full Text] [Related]
[Next] [New Search]
